loading

Aptevo Therapeutics Inc Azioni (APVO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
4.48%
3.752
3.591 3.887 5.462 4.168
Operating Income/Loss
9.38%
-6.983
-6.384 -6.561 -8.178 -7.756
Income/Loss From Continuing Operations Before Tax
10.30%
-6.834
-6.196 -6.334 -7.948 2.773
Income/Loss From Continuing Operations After Tax
10.30%
-6.834
-6.196 -6.334 -7.948 1.827
Income/Loss From Discontinued Operations, Net Of Tax
100.00%
-
0.293 - - 0.946
Net Income/Loss
15.77%
-6.834
-5.903 -6.334 -7.948 2.773
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
78.73%
0.6867
3.2281 12.58 6.4822 7.0223
Diluted Average Shares
78.73%
0.6867
3.2281 12.58 6.4822 7.0223
Basic Earnings Per Share
7,007%
-9.95
-0.14 -0.50 -1.23 0.39
Diluted Earnings Per Share
7,007%
-9.95
-0.14 -0.50 -1.23 0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):